Page 35

Journal_de_Pharmacie_de_Belgique_n3_ septembre_2015

Journal de Pharmacie de Belgique - 97ème année n° 3 - septembre 2015 35 32 Coachis Santé (2014) Compte-rendu réunion plénière Club Utilisateurs du 1er avril 2014. 33 Douillard J.Y., Cunningham D., Roth A.D., Navarro M., James R.D., Karasek P., Jandik P., Iveson T., Carmichael J., Alakl M., Gruia G., Awad L., Rougier P. (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. The Lancet 355, 1041-1047. 34 Maindrault-Goebel F., Louvet C., André T., Carola E., Lotz J.P., Molitor J.L., Garcia M.L., Gilles-Amar V., Izrael V., Krulik M., De Gramont A. (1999) Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). European Journal of Cancer 35, 1338-1342. 35 De Gramont A., Bosset J.F., Milan C., Rougier P., Bouché O., Etienne P.L., Morvan F., Louvet C., Guillot T., François E., Bedenne L. (1997) Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study. Journal of Clinical Oncology 15, 808-815. 36 Leth-Miller D. (2007) Dose-banding of gemcitabine. European Journal of Hospital Pharmacy 2, 52. 37 North of England cancer Network. {En ligne} www.networks.nhs.uk consulté le 10/03/2014. 38 Arrêté royal du 20 janvier 2009 portant instruction pour les pharmaciens. Moniteur Belge du 30/01/2009, 7229. 39 Sewell G., Kaestner S. (2010) Dosebanding of cancer chemotherapy. Hospital Pharmacy Europe 51, 31-32. 40 Hoppe-Tichy T. (2010) Current challenges in European oncology pharmacy practice. Journal of Oncology Pharmacy Practice 16, 9-18. étude


Journal_de_Pharmacie_de_Belgique_n3_ septembre_2015
To see the actual publication please follow the link above